Argenica Therapeutics Ltd (AGN) — Cash Flow Quality Index

Latest as of December 2020: -3.94x

Argenica Therapeutics Ltd (AGN) has a Cash Flow Quality Index of -3.94x as of December 2020. Operating cash flow of AU$-256.95K is below net income of AU$65.24K, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Argenica Therapeutics Ltd for the complete picture of this company's asset base.

Cash Flow Quality Index

-3.94x

Operating CF / Net Income

Operating Cash Flow

AU$-256.95K

AUD

Net Income

AU$65.24K

AUD

Data as of

Dec 2020

Most recent filing

Annual Cash Flow Quality Index for Argenica Therapeutics Ltd (None–None)

Year-by-year earnings quality comparison for Argenica Therapeutics Ltd. For live market cap and the full company financial profile, see Argenica Therapeutics Ltd stock valuation.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.